ABSTRACT
Background: Hypertensive with impaired fasting glucose is the basic expression of metabolic syndrome. Objectives: To study the IR and the correlation between Fasting Plasma Insulin (FPI) and Fasting Plasma Glucose (FPG) concentration in hypertensive patients with Impaired Fasting Glucose (IFG). Subjects and method: The descriptive, cross-sectional study was carried out on 38 hypertensive patients with IFG (IFG group) and 30 hypertensive patients without IFG (control group). The data were collected and analyzed by SPSS 11.5 software. Results:The FPI and IR index in the IFG group were 14.6+/-5.2 micro mol/ml and 3. 94+/- l.40, respectively, higher than in the control group (9.6+/-4.2 micro mol/ml and 2.17+/-0.99/ respectively) with p<0.00l. There was a positive correlation between FPI and FPG systolic blood and diastolic blood pressure/ with correlation coefficients were 0.4/ 0.48 and 0.46/ respectively (p<0.00l). Conclusion: There was an increase of FPI and IR index in the hypertensive patients with IFG compared to those without IFG. \r\n', u'\r\n', u'
Subject(s)
Insulin ResistanceABSTRACT
Background: Heart failure is a common clinical condition and is the late stage of most cardiovascular diseases. Heart rate disorder is one of the causes of deaths in patients with chronic heart failure. There is few number of studies on Heart Rate Variability (HRV) in Vietnam. Objective: To study the change of HRV time in patients with chronic heart failure. Subject and Method: A prospective, descriptive and cross-sectional study was carried out on 105 subjects including 73 patients with chronic heart failure and 42 normal persons as controls. Time domain measurements of HRV were calculated from 24 hour electrocardiographic Holter (Holter WIN P-V, USA) on all 105 subjects. In the chronic heart failure group, there were 51 men and 22 women with the mean age of 62.8+/-11.2, control group including 30 men and 12 women with the mean age of 61.5+/-5.7. Results and conclusion: (1) There was a decrease of time domain of HRV showed the decrease of parasympathetic tone in patients with chronic heart diseases. (2) The higher degree of heart failure, the lower the time domain of HRV.
ABSTRACT
Background: The results of previous studies showed that there was an increase of serum TNF-alpha in diabetes mellitus type 2.\r\n', u'Objectives: To study the change of serum TNF-alpha and the relationship between TNF-alpha and various anthropometrics indexes. \r\n', u'Subjects and methods: The controlled, prospective, cross-sectional, descriptive study was performed on 117 patients with diabetes mellitus type 2 (62 male and 55 female, average age of 60.1 10.3) and 39 control subjects (21 male and 18 female, average age of 63.3 11.1).\r\n', u'Results:The concentration of serum TNF-alpha of diabetes mellitus type 2 group was significantly higher than that of control subjects (80.45 \xb1 96.57pg/ml in type 2 diabetes group and 15.8 \xb1 48.72 pg/ml in control subjects). In diabetes mellitus patients with elevated serum TNF-alpha, body mass index (BMI) (22.93 \xb1 2.67kg/m2), waist circumference (WC) (82.4 \xb1 7.51cm) were significantly higher than those in diabetes mellitus patients with normal serum TNF alpha (21.59 \xb1 2.76kg/m2, 79 \xb18.15cm, respectively)\r\n', u'Conclusion: There was an increase of serum TNF alpha in diabetes mellitus type 2 and there was the relationship between TNF alpha with BMI and WC.\r\n', u'\r\n', u'
Subject(s)
Body Mass Index , Waist Circumference , Diabetes Mellitus, Type 2ABSTRACT
Monitoring the heart rate variability is a simple non-invasive method for evaluating the influences of drug therapy, motor, psychological therapy and stress on the functions of autonomic nervous system. The heart rate variability is applied widely in clinical as well as pathological mechanism of cardiovascular diseases and non-cardio vascular diseases in the world. Curently, many health care facilities installed the holder for monitoring the blood pressure and heart rate in Vietnam. Therefore, this method is available ready for studying, diagnosing and monitoring the treatment.